Naproxen Sodium
- Product NDC
- 71335-1925
- Requested package NDC
- 71335-1925-5
- 11-digit product format
- 713351925
- Labeler code
- 71335
- Product ID
- 71335-1925_5106647a-1c82-4ebe-95f3-db46fb2398db
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Naproxen Sodium
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA200629
- Marketing category
- ANDA
- Marketing start
- 2011-10-31
- Substance
- NAPROXEN SODIUM
- Active strength
- 275 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A200629-001 | NAPROXEN SODIUM | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2011-10-31 | |
| A200629-002 | NAPROXEN SODIUM | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2011-10-31 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A200629-001 | AB |
| A200629-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A200629-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2011-10-31 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A200629-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2011-10-31 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A200629-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2011-10-31 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A200629-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2011-10-31 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A200629-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2011-10-31 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A200629-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2011-10-31 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A200629-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2011-10-31 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A200629-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2011-10-31 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A200629-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2011-10-31 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A200629-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2011-10-31 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A200629-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2011-10-31 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A200629-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2011-10-31 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A200629-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2011-10-31 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A200629-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2011-10-31 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A200629-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2011-10-31 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A200629-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2011-10-31 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A200629-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2011-10-31 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A200629-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2011-10-31 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A200629-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2011-10-31 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A200629-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2011-10-31 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A200629-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2011-10-31 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A200629-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2011-10-31 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A200629-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2011-10-31 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A200629-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2011-10-31 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A200629-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2011-10-31 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A200629-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2011-10-31 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A200629-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2011-10-31 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A200629-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2011-10-31 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A200629-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2011-10-31 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A200629-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2011-10-31 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A200629-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2011-10-31 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | A200629-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2011-10-31 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A200629-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2011-10-31 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A200629-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2011-10-31 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A200629-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2011-10-31 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | A200629-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2011-10-31 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A200629-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2011-10-31 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | A200629-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2011-10-31 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A200629-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2011-10-31 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | A200629-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2011-10-31 | 74a2ff9319b5… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A200629-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A200629-002 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A200629-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A200629-002 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A200629-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A200629-002 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A200629-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A200629-002 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A200629-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A200629-002 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A200629-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A200629-002 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A200629-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A200629-002 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A200629-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A200629-002 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A200629-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A200629-002 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A200629-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A200629-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A200629-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A200629-002 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A200629-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A200629-002 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A200629-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A200629-002 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A200629-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A200629-002 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A200629-001 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A200629-002 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A200629-001 | AB | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A200629-002 | AB | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A200629-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A200629-002 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A200629-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A200629-002 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A200629-001 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A200629-002 | AB | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A200629-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A200629-002 | AB | 1 | 74a2ff9319b5… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Naproxen Sodium
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| NAPROXEN SODIUM | 275 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 9TN87S3A3C | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 849398 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1c2325f7-1d65-429d-a64d-6ab075df1c20 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| fef6ad89-235f-4274-ba49-a8e53642473e | Product name | 2 | 20250225 |
| 594e2c86-3079-4e6e-96c9-48f7a8afc78d | Product name | 1 | 20230718 |
| 87fed3e6-8fba-48ef-96b0-3a7fb54b96ff | Product name | 3 | 20230306 |
| b5fdaaec-7251-4da6-9cb2-4e9e76939ec8 | Product name | 1 | 20200623 |
| e76dbbc1-775d-722c-08ff-ed45e8a80def | Product name | 3 | 20181002 |
| 6f4f4521-fd56-1ae6-888b-3b021bd75c7c | Product name | 1 | 20140508 |
| ce67e27d-1d21-5465-4409-b0662dd99d4d | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71335-1925-1 | Naproxen Sodium | 60 in 1 BOTTLE | TABLET, FILM COATED | 60 | 104 | |
| 71335-1925-2 | Naproxen Sodium | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 104 | |
| 71335-1925-3 | Naproxen Sodium | 42 in 1 BOTTLE | TABLET, FILM COATED | 42 | 104 | |
| 71335-1925-4 | Naproxen Sodium | 20 in 1 BOTTLE | TABLET, FILM COATED | 20 | 104 | |
| 71335-1925-5 | Naproxen Sodium | 120 in 1 BOTTLE | TABLET, FILM COATED | 120 | 104 | |
| 71335-1925-6 | Naproxen Sodium | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 104 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 71335-1925 | NAPROXEN SODIUM TABLET, FILM COATED [BRYANT RANCH PREPACK] | 103 | Current NDC, Legacy NDC, 6 package rows | 20250226_1c2325f7-1d65-429d-a64d-6ab075df1c20.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Naproxen Sodium | NAPROXEN SODIUM | Bryant Ranch Prepack | 1c2325f7-1d65-429d-a64d-6ab075df1c20 | 2026-01-28 | Boxed warning, Warnings, Adverse reactions | 200629 ANDA200629 71335-1925-5 71335-1925 71335192505 |
| Naproxen Sodium | NAPROXEN SODIUM | Bryant Ranch Prepack | 0e7697ad-25c6-4405-9f9b-791633cb1ef7 | 2025-11-18 | Boxed warning, Warnings, Adverse reactions | 200629 ANDA200629 |
| Naproxen Sodium | NAPROXEN SODIUM | Aurobindo Pharma Limited | 37b264f9-b46d-4635-8fab-246b1e08b653 | 2025-09-05 | Boxed warning, Warnings, Adverse reactions | 200629 ANDA200629 |
| Naproxen Sodium | NAPROXEN SODIUM | Proficient Rx LP | 397db794-027c-4a89-993e-07c208b457a3 | 2020-09-01 | Boxed warning, Warnings, Adverse reactions | 200629 ANDA200629 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 849398 | naproxen sodium 275 MG Oral Tablet | PSN | 1c2325f7-1d65-429d-a64d-6ab075df1c20 | 104 |
| 849398 | naproxen sodium 275 MG Oral Tablet | SCD | 1c2325f7-1d65-429d-a64d-6ab075df1c20 | 104 |
| 849398 | naproxen sodium 275 MG (as naproxen 250 MG) Oral Tablet | SY | 1c2325f7-1d65-429d-a64d-6ab075df1c20 | 104 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 71335-1925-5 | 71335192505 | 120 TABLET, FILM COATED in 1 BOTTLE (71335-1925-5) | 2025-01-30 | 0000-00-00 | No | No | Current |